Arena Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Arena Pharmaceuticals ( ARNA) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. This stock is trading up 8.7% to $7.69 in recent trading.

Today's Range: $7.20-$7.75

52-Week Range: $1.23-$7.23

Volume: 26.1 million

Three-Month Average Volume: 15.4 million

From a technical perspective, ARNA is ripping higher here on monster volume. This move is a continuation pattern from yesterday when the stock broke out above some past overhead resistance at $7.01 with high volume.

Traders should continue to look for long-biased trades as long as ARNA is trending above $7.01, and once it triggers its next big breakout. The next major breakout will trigger for ARNA once it takes out $8 with high-volume. Look for a sustained move or close over $8 with volume that's near or above 15.4 million shares. If we get that action soon, then ARNA could easily continue its uptrend towards $10 in the near future.

Arena shows up on a list of Hot Biotech Stocks Traded by Hedge Funds.

If you liked this article you might like

A Stampede of Buying: Cramer's 'Mad Money' Recap (Monday 9/11/17)

Allergan, USG Corp, Arena Pharmaceuticals: 'Mad Money' Lightning Round

These Stocks Have Changed Direction

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says